Results 61 to 70 of about 651,564 (257)

Alcohol Drinking in Never Users of Tobacco, Cigarette Smoking in Never Drinkers, and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium [PDF]

, 2017
Background At least 75% of head and neck cancers are attributable to a combination of cigarette smoking and alcohol drinking. A precise understanding of the independent association of each of these factors in the absence of the other with the risk of ...
Benhamou, Simone, Berthiller, Julien, Boffetta, Paolo, Brennan, Paul, Castellsague, Xavier, Chen, Chu, Curado, Maria Paula, Daudt, Alexander W., Eluf-Neto, Jose, Fabianova, Eleonora, Franceschi, Silvia, Hashibe, Mia, Hayes, Richard B., Herrero, Rolando, Koifman, Sergio, La Vecchia, Carlo, Lazarus, Philip, Levi, Fabio, Maso, Luigino Dal, Mates, Dana, Matos, Elena, Menezes, Ana, Muscat, Joshua, Olshan, Andrew F., Rudnai, Peter, Schwartz, Stephen M., Smith, Elaine, Sturgis, Erich M., Szeszenia-Dabrowska, Neonilia, Talamini, Renato, Wei, Qingyi, Winn, Deborah M., Wünsch-Filho, Victor, Zaridze, David, Zatonski, Witold, Zhang, Zuo-Feng   +35 more
core  

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

Cancer, 2019
Because the addition of nimotuzumab to chemoradiation in patients with locally advanced head and neck cancer improved outcomes in a phase 2 study, the authors conducted a phase 3 study to confirm these findings.
V. Patil, V. Noronha, A. Joshi, J. Agarwal, S. Ghosh-Laskar, A. Budrukkar, V. Murthy, T. Gupta, M. Mahimkar, S. Juvekar, S. Arya, A. Mahajan, A. Agarwal, N. Purandare, V. Rangarajan, A. Balaji, S. Chaudhari, S. Banavali, S. Kannan, A. Bhattacharjee, A. D'cruz, P. Chaturvedi, P. Pai, D. Chaukar, G. Pantvaidya, D. Nair, S. Nair, A. Deshmukh, S. Thiagarajan, V. Mathrudev, Aparna Manjrekar, S. Dhumal, K. Maske, Arti Bhelekar, K. Nawale, A. Chandrasekharan, N. Pande, A. Goel, V. Talreja, V. Simha, S. Srinivas, Rohit Swami, D. Vallathol, H. Dsouza, Sameer Shrirangwar, Siddharth Turkar, G. Abraham, A. Thanky, U. Patel, Manishkumar Pandey, K. Prabhash   +50 more
semanticscholar   +1 more source

Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma

Frontiers in Immunology, 2023
In the tumor milieu of head and neck squamous cell carcinoma (HNSCC), distinct B cell subpopulations are present, which exert either pro- or anti-tumor activities.
Jiantong Bao, Jiantong Bao, Annika C. Betzler, Jochen Hess, Jochen Hess, Cornelia Brunner   +5 more
doaj   +1 more source

Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee [PDF]

, 2017
Head and neck squamous cell cancer (HNSCC) is the sixth leading cause of cancer-related deaths worldwide. These tumors are commonly diagnosed at advanced stages and mortality rates remain high.
Budach, W., Knecht, R., Lacombe, D., Langendijk, J. A., Licitra, L., Ozsahin, M., Psyrri, A., Schuuring, E., Vermorken, J. B.   +8 more
core  

Orosphere assay: A method for propagation of head and neck cancer stem cells [PDF]

, 2012
Background Recent evidence suggests that head and neck squamous cell carcinomas (HNSCCs) harbor a small subpopulation of highly tumorigenic cells, designated cancer stem cells.
Krishnamurthy, Sudha, Nör, Jacques E.
core   +1 more source

Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer

Experimental and Molecular Medicine, 2019
Epidermal growth factor receptor (EGFR) overexpression is common in head and neck squamous cell carcinoma. Targeted therapy specifically directed towards EGFR has been an area of keen interest in head and neck cancer research, as EGFR is potentially an ...
H. Byeon, Minhee Ku, Jaemoon Yang
semanticscholar   +1 more source

Adaptive radiotherapy for head and neck cancer

Cancers of the Head & Neck, 2020
BackgroundAlthough there have been dramatic improvements in radiotherapy for head and neck squamous cell carcinoma (HNSCC), including robust intensity modulation and daily image guidance, these advances are not able to account for inherent structural and
H. Morgan, D. Sher
semanticscholar   +1 more source

Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers. [PDF]

, 2011
MicroRNAs (miRNAs) are small noncoding RNAs that involved in various cancer-related cellular processes. Diverse studies on expression profiling of miRNAs have been performed and the data showed that some miRNAs are up-regulated or down-regulated in ...
Ab Mutalib, Nurul-Syakima, Abdul Rahman, Sabariah, Cheah, Yoke Kqueen, Lee, Learn Han, Mohan Singh, Avatar Singh, Mohd Sidik, Shiran   +5 more
core   +1 more source

Personalized treatment of 95 poorly differentiated thyroid cancer/anaplastic thyroid cancer in 2019–2023

European Thyroid Journal
Background: Poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC) are both rare and aggressive thyroid cancers. Advances in targeted therapy and immunotherapy have changed treatment strategies and improved prognosis in these ...
Nai-Si Huang, Jia-Ying Chen, Wen-Jun Wei, Jia-Qian Hu, Yun-Jun Wang, Wan-Lin Liu, Qing Guan, Tuan-Qi Sun, Yu-Long Wang, Jun Xiang, Qing-Hai Ji, Dong-Mei Ji, Yu Wang   +12 more
doaj   +1 more source

Improving therapeutic ratio In head and neck cancer with adjuvant and cisplatin-based treatments [PDF]

, 2013
Advanced head and neck cancers are difficult to manage despite the large treatment arsenal currently available. The multidisciplinary effort to increase disease-free survival and diminish normal tissue toxicity was rewarded with better locoregional ...
Marcu, L.
core   +3 more sources